A virtual meeting held by the UK Cell and Gene Catapult shared a year of progress, and thoughts on the challenges that lie ahead for British ATMPs.

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

Pfizer’s trial of a new medicine for COVID-19, produced with support from the US Department of Energy, could improve access to treatment.

A team at the University of Bath have found a more efficient way to produce drugs using a catalyst powered by 420 nanometer blue light.

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

Integrating digital technologies into your operations can make all the difference to the formulation process.

Adoption of organ-on-a-chip technology is on the rise, but misconceptions remain prevalent, says Tomasz Kostrzewski of CN Bio.

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.